You are here

  • Home
  • Archive
  • Volume 12, Issue 2
  • Association between pharmaceutical modulation of oestrogen in postmenopausal women in Sweden and death due to COVID-19: a cohort study

Article info

Article menu

Download PDFPDF

Epidemiology
Original research
Association between pharmaceutical modulation of oestrogen in postmenopausal women in Sweden and death due to COVID-19: a cohort study

Authors

  • Malin Sund Department of Surgical and Perioperative Sciences, Umeå University Faculty of Medicine, Umeå, Sweden Department of Surgery, Univerisity of Helsinki and Helsinki University Hospital, Helsinki, Finland PubMed articlesGoogle scholar articles
  • Osvaldo Fonseca-Rodríguez Department of Clinical Microbiology, Umeå University Faculty of Medicine, Umeå, Sweden PubMed articlesGoogle scholar articles
  • Andreas Josefsson Department of Surgical and Perioperative Sciences, Umeå University Faculty of Medicine, Umeå, Sweden Department of Urology, University of Gothenburg, Gothenburg, Sweden Wallenberg Center for Molecular Medicine, Umeå University, Umeå, Sweden PubMed articlesGoogle scholar articles
  • Karin Welen Department of Urology, University of Gothenburg, Gothenburg, Sweden PubMed articlesGoogle scholar articles
  • Anne-Marie Fors Connolly Department of Clinical Microbiology, Umeå University Faculty of Medicine, Umeå, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Anne-Marie Fors Connolly; anne-marie.fors.connolly{at}umu.se
View Full Text

Citation

Sund M, Fonseca-Rodríguez O, Josefsson A, et al
Association between pharmaceutical modulation of oestrogen in postmenopausal women in Sweden and death due to COVID-19: a cohort study
BMJ Open 2022;12:e053032. doi: 10.1136/bmjopen-2021-053032

Publication history

  • Received May 3, 2021
  • Accepted November 21, 2021
  • First published February 14, 2022.
Online issue publication 
February 14, 2022
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.